G01N 2333/90241
Acting on single donors with incorporation of molecular oxygen, i.e. oxygenases
Official title: acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
G01N2333/90241 (Acting on single donors with incorporation of molecular oxygen, i.e. oxygenases) appears on 167 US grants and 260 published applications in this corpus.
Search patents in G01N- Granted patents
- 167
- Published applications
- 260
- Assignees
- 144
- Inventors
- 529
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 5 |
| 2002 | 2 | 3 |
| 2003 | 7 | 4 |
| 2004 | 0 | 5 |
| 2005 | 2 | 6 |
| 2006 | 4 | 4 |
| 2007 | 5 | 6 |
| 2008 | 2 | 2 |
| 2009 | 0 | 8 |
| 2010 | 2 | 6 |
| 2011 | 3 | 8 |
| 2012 | 4 | 9 |
| 2013 | 3 | 8 |
| 2014 | 11 | 11 |
| 2015 | 11 | 19 |
| 2016 | 14 | 18 |
| 2017 | 9 | 22 |
| 2018 | 13 | 10 |
| 2019 | 13 | 13 |
| 2020 | 17 | 19 |
| 2021 | 8 | 16 |
| 2022 | 5 | 8 |
| 2023 | 10 | 6 |
| 2024 | 6 | 16 |
| 2025 | 8 | 13 |
| 2026 | 4 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for screening compounds for bactericidal activity and for determining the sensitivity of bacterial samples7 Apr 2026US 12,595,504 B2Centre National de la Recherche Scientifique (CNRS)
- Plant pathogen effector and disease resistance gene identification, compositions, and methods of use3 Mar 2026US 12,565,662 B2Huazhong Agricultural University
- Methods and compositions for treating 4-hydroxyphenylpyruvate dioxygenase-like (HPDL)-related diseases or disorders24 Feb 2026US 12,558,329 B2New York University
- Compositions and methods for protein detection10 Feb 2026US 12,546,783 B2Syngenta Crop Protection AG
- Treatment of respiratory disorders with arachidonate 15-lipoxygenase (ALOX15) inhibitors18 Nov 2025US 12,472,241 B2Regeneron Pharmaceuticals, Inc.
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Treatment Of Inflammatory Bowel Disease In Subjects Having Loss-Of-Function (LOF) Gene Variants27 Aug 2026US 2026/0250767 A1Regeneron Pharmaceuticals, Inc.
- Covalent target engagement27 Aug 2026US 2026/0251633 A1Promega Corporation
- Biomarkers for huntington disease stratification, methods and uses thereof13 Aug 2026US 2026/0235626 A1
- Biosensor for water analysis30 Jul 2026US 2026/0219194 A1Biocell Analytica Uppsala AB
Most cited
By later US patents
- Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity55US 5,543,297 AMerck Frosst Canada, Inc. · 1996
- Luminescence detection workstation37US 6,518,068 B1Tropix, Inc. · 2003
- Noninvasive detection of colorectal cancer and other gastrointestinal pathology36US 6,630,314 B22003
- Method for increasing luminescence assay sensitivity33US 7,118,878 B1Promega Corporation · 2006
- Vaginal indicator to detect biomarkers of good health19US 9,034,593 B2Kimberly-Clark Worldwide, Inc. · 2015